Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds HC Wainwright & Co. Downgrades Oncorus to Neutral

HC Wainwright & Co. Downgrades Oncorus to Neutral

HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Oncorus (NASDAQ:ONCR) from Buy to Neutral.

December 6, 2022

1 minute read

HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Oncorus (NASDAQ:ONCR) from Buy to Neutral.

RBC Capital Downgrades Constellation Energy to Sector Perform, Announces $91 Price Target

January 17, 6:14 AM

RBC Capital analyst Shelby Tucker downgrades Constellation Energy (NASDAQ:CEG) from Outperform to Sector Perform and announces $91 price target.

October 24, 8:28 AM

Paramount Global (NASDAQ: PARA) postponed the eighth installment of the "Mission: Impossible" franchise by a year as

March 8, 7:23 AM

HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Hldgs (NASDAQ:IMCR) with a Buy and maintains $90 price target.

September 11, 1:00 PM

Piper Sandler has decided to maintain its Overweight rating of SLB (NYSE:SLB) and raise its price target from…